The Internet of Bodies Is Coming: HabitCure’s Approach to Reading Daily Body Signals

Danny Lieberman hosts episode 78 of the Life Sciences Today podcast with guest Rick Duchin, founder and CEO of HabitCure. The central theme is the emergence of an "Internet of Bodies"—connected systems that read physiological signals continuously and translate them into timely answers for patients and care teams. The conversation focuses on how HabitCure builds value, who buys the product, competitive threats, and where the company plans to go next.

HabitCure processes daily bodily signals and converts them into actionable insights. The system is described as reading the signals your body sends and turning them into the answers you needed before the moment arrived. The emphasis is on continuous, anticipatory guidance rather than episodic alerts.

The podcast covers buyer profiles: healthcare organizations and life sciences companies that can use continuous-body-signal insights to improve care, patient engagement, or research. The model positions HabitCure as selling into clinical and enterprise channels rather than only to consumers.

Product roadmap and near-term priorities

Duchin lists three priorities for customers over the next 12 months. These are practical product and service goals aimed at expanding utility and adoption among paying buyers. The roadmap centers on improving signal-to-insight conversion, deepening clinical validation, and integrating with buyer workflows.

The podcast explores how HabitCure captures value—pricing, commercial models, and how enterprise customers realize ROI when continuous bodily signals lead to measurable behavior change, clinical outcomes, or operational efficiencies.

Lieberman asks about the biggest anti-patterns HabitCure sees. The conversation identifies common mistakes: treating physiologic signals as siloed telemetry, over-relying on novelty sensors without established clinical pathways, and misaligning incentives when deploying body-connected products into healthcare systems.

The episode is available across podcast platforms including Apple Podcasts, Spotify, Amazon Music, iHeartRadio, Pandora, YouTube Music, and RSS. Healthcare IT Today hosts both audio and video versions.

• If you represent a healthcare buyer: evaluate where continuous physiologic insights could reduce friction in care pathways or improve adherence.
• If you build connected-health products: map signal sources to clinical workflows early, and define measurable outcomes tied to buyer ROI.
• If you follow life sciences commercialization: watch how companies like HabitCure price enterprise access to continuous-health insights and validate clinical benefit.

Guest: Rick Duchin, Founder & CEO, HabitCure Episode: Life Sciences Today Podcast, Episode 78

Where to listen: Apple Podcasts, Spotify, Amazon Music, iHeartRadio, Pandora, YouTube Music, RSS, Healthcare IT Today